Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm reports osteoarthritis pain reduced by 50%

Mar 1, 2018 at 2:39 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment